Cervical intraepithelial neoplasia grade 2/3
Therapeutic area
Reproductive Health
Rare disease
No
- Definition
- A neoplastic process in the cervix characterized by morphologic features of both moderate and severe intraepithelial neoplasia.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Cervical intraepithelial neoplasia grade 2/3
- Therapeutic area
- Reproductive Health
- cervical intraepithelial neoplasia grade 2/3
- CIN 2/3
- All therapeutic areas
- Reproductive Health
- Severity
- Moderate
- MONDO ID
- MONDO:0006137
- Parent condition
- MONDO:0022394
Related records
Broader conditions (6)
- Cervical intraepithelial neoplasia
- Disease
- Disease by body system or component
- Dysplasia of cervix
- Human disease
- Reproductive system disorder
Trials (39)
- 5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
- A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
- A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.
- Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
- Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
- Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
- Biomarkers Predictive for Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Evolvement
- Cervical Cancer Screening With Human Papillomavirus Testing
- Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
- Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
- Conservative Management of CIN2 Lesions and Biomarkers Evaluation
- Digital Telecytology for Triage of HPV-Positive Women in Cameroon
- Empowering Women - Shared Decision Making in Managing Cervical Precancer
- Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
- Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
- Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
- Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
- Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
Drugs in development (1)
- Artesunate Phase 2